Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Sagar Lonial
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Phenomena
Concepts & Ideas
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
21
Waller, Edmund
11
Langston, Amelia
9
Stadtmauer, Edward
8
Anderson, Kenneth
7
Cavenagh, Jamie
7
Chen, Jing
7
Heffner, Leonard
7
Redei, Istvan
6
Richardson, Paul
6
Khuri, Fadlo
6
Harousseau, Jean-Luc
6
Esseltine, Dixie
5
Dong, Shaozhong
5
Bladé, Joan
5
Kang, Sumin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Sagar Lonial (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Harvey R D; Nettles J; Wang B; Sun S-Y; Lonial S
Commentary on Perrone et al.: 'vitamin C: not for breakfast anymore...if you have myeloma'.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(11):1939-40.
-
2009: Gleason Charise; Nooka Ajay; Lonial Sagar
Supportive therapies in multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):971-9.
-
2009: Kumar Shaji; Giralt Sergio; Stadtmauer Edward A; Harousseau Jean L; Palumbo Antonio; Bensinger William; Comenzo Raymond L; Lentzsch Suzanne; Munshi Nikhil; Niesvizky Ruben; San Miguel Jesus; Ludwig Heinz; Bergsagel Leif; Blade Joan; Lonial Sagar; Anderson Kenneth C; Tosi Patrizia; Sonneveld Pieter; Sezer Orhan; Vesole David; Cavo Michele; Einsele Hermann; Richardson Paul G; Durie Brian G M; Rajkumar S Vincent;
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Blood 2009;114(9):1729-35.
-
2009: Lonial Sagar
Risky business in myeloma.
Blood 2009;114(3):496-7.
-
2009: Subramaniyam Veerappan; Waller Edmund K; Murrow Jonathan R; Manatunga Amita; Lonial Sagar; Kasirajan Karthikeswar; Sutcliffe Diane; Harris Wayne; Taylor W Robert; Alexander R Wayne; Quyyumi Arshed A
Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease.
American heart journal 2009;158(1):53-60.e1.
-
2009: Richardson Paul G; Xie Wanling; Mitsiades Constantine; Chanan-Khan Asher A; Lonial Sagar; Hassoun Hani; Avigan David E; Oaklander Anne Louise; Kuter David J; Wen Patrick Y; Kesari Santosh; Briemberg Hannah R; Schlossman Robert L; Munshi Nikhil C; Heffner L Thompson; Doss Deborah; Esseltine Dixie-Lee; Weller Edie; Anderson Kenneth C; Amato Anthony A
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3518-25.
-
2009: Lonial Sagar; Cavenagh Jamie
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma.
British journal of haematology 2009;145(6):681-708.
-
2009: Kaufman Jonathan; Lonial Sagar
Treatment of multiple myeloma: whence truth over belief?
Oncology (Williston Park, N.Y.) 2009;23(5):420, 423.
-
2009: Kang Sumin; Elf Shannon; Dong Shaozhong; Hitosugi Taro; Lythgoe Katherine; Guo Ailan; Ruan Hong; Lonial Sagar; Khoury Hanna J; Williams Ifor R; Lee Benjamin H; Roesel Johannes L; Karsenty Gerard; Hanauer André; Taunton Jack; Boggon Titus J; Gu Ting-Lei; Chen Jing
Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
Molecular and cellular biology 2009;29(8):2105-17.
-
2009: Richardson Paul G; Sonneveld Pieter; Schuster Michael W; Stadtmauer Edward A; Facon Thierry; Harousseau Jean-Luc; Ben-Yehuda Dina; Lonial Sagar; Goldschmidt Hartmut; Reece Donna; Bladé Joan; Boccadoro Mario; Cavenagh Jamie D; Boral Anthony L; Esseltine Dixie-Lee; Wen Patrick Y; Amato Anthony A; Anderson Kenneth C; San Miguel Jesus
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
British journal of haematology 2009;144(6):895-903.
-
2008: Lonial Sagar; Richardson Paul G; San Miguel Jesús; Sonneveld Pieter; Schuster Michael W; Bladé Joan; Cavenagh Jamie; Rajkumar S Vincent; Jakubowiak Andrzej J; Esseltine Dixie-Lee; Anderson Kenneth C; Harousseau Jean-Luc
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
British journal of haematology 2008;143(2):222-9.
-
2008: Chanan-Khan Asher; Sonneveld Pieter; Schuster Michael W; Stadtmauer Edward A; Facon Thierry; Harousseau Jean-Luc; Ben-Yehuda Dina; Lonial Sagar; Goldschmidt Hartmut; Reece Donna; Neuwirth Rachel; Anderson Kenneth C; Richardson Paul G
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4784-90.
-
2008: Murali S; Winton E; Waller E K; Heffner L T; Lonial S; Flowers C; Kaufman J; Arellano M; Lechowicz M J; Mann K P; Khoury H J; Langston A A
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
Bone marrow transplantation 2008;42(8):529-34.
-
2008: Lonial Sagar; Torre Claire; David Ebenezer; Harris Wayne; Arellano Martha; Waller Edmund K
Regulation of alloimmune responses by dendritic cell subsets.
Experimental hematology 2008;36(10):1309-17.
-
2008: Lonial Sagar
Practical considerations for multiple myeloma: an overview of recent data and current options.
Clinical lymphoma & myeloma 2008;8 Suppl 4():S144-8.
-
2008: David Ebenezer; Sinha Rajni; Chen Jing; Sun Shi-Yong; Kaufman Jonathan L; Lonial Sagar
Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5090-8.
-
2008: Silberman Jeannine; Lonial Sagar
Review of peripheral neuropathy in plasma cell disorders.
Hematological oncology 2008;26(2):55-65.
-
2008: Arellano Martha; Lonial Sagar
Clinical uses of GM-CSF, a critical appraisal and update.
Biologics : targets & therapy 2008;2(1):13-27.
-
2008: Lonial Sagar; Gertz Morie A
Eliminating the complete response penalty from myeloma response assessment.
Blood 2008;111(6):3297-8.
-
2008: Dong S; Kang S; Lonial S; Khoury H J; Viallet J; Chen J
Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(3):572-7.
-
2008: Gladney S Pierson; Lonial Sagar; Kaufman Jonathan L
Multiple myeloma presenting with advanced renal failure: a case report and new treatment options.
Clinical lymphoma & myeloma 2008;8(1):52-4.
-
2008: Kang Sumin; Dong Shaozhong; Guo Ailan; Ruan Hong; Lonial Sagar; Khoury Hanna Jean; Gu Ting-Lei; Chen Jing
Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
The Journal of biological chemistry 2008;283(8):4652-7.
-
2007: Lonial Sagar
Multiple myeloma: novel approaches for relapsed disease.
Clinical lymphoma & myeloma 2007;8 Suppl 1():S18-23.
-
2007: Harvey R Donald; Lonial Sagar
PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma.
Future oncology (London, England) 2007;3(6):639-47.
-
2007: Weber Donna M; Chen Christine; Niesvizky Ruben; Wang Michael; Belch Andrew; Stadtmauer Edward A; Siegel David; Borrello Ivan; Rajkumar S Vincent; Chanan-Khan Asher Alban; Lonial Sagar; Yu Zhinuan; Patin John; Olesnyckyj Marta; Zeldis Jerome B; Knight Robert D;
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.
The New England journal of medicine 2007;357(21):2133-42.
-
2007: Richardson Paul G; Sonneveld Pieter; Schuster Michael; Irwin David; Stadtmauer Edward; Facon Thierry; Harousseau Jean-Luc; Ben-Yehuda Dina; Lonial Sagar; Goldschmidt Hartmut; Reece Donna; Miguel Jesus San; Bladé Joan; Boccadoro Mario; Cavenagh Jamie; Alsina Melissa; Rajkumar S Vincent; Lacy Martha; Jakubowiak Andrzej; Dalton William; Boral Anthony; Esseltine Dixie-Lee; Schenkein David; Anderson Kenneth C
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.
Blood 2007;110(10):3557-60.
-
2007: Stadtmauer Edward A; Lonial Sagar; Vesole David H; Abonour Rafat; Alsina Melissa; Badros Ashraf; Comenzo Raymond; Durie Brian; Giralt Sergio; Hussein Mohamad; Jakubowiak Andrzej; Mehta Jayesh; Niesvizky Ruben; Orlowski Robert; Siegel David; Singhal Seema; Vescio Robert; Wang Michael; Zangari Maurizio; Munshi Nikhil C
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Clinical advances in hematology & oncology : H&O 2007;5(10 Suppl 15):7-19, quiz 21-2.
-
2007: Mihelic Ronald; Kaufman Jonathan; Lonial Sagar; Flowers Christopher
Maintenance therapy in lymphoma.
Clinical lymphoma & myeloma 2007;7(8):507-13.
-
2007: Lonial Sagar
Complete remission of multiple myeloma.
Clinical advances in hematology & oncology : H&O 2007;5(9):671-2, 675.
-
2007: Kang Sumin; Dong Shaozhong; Gu Ting-Lei; Guo Ailan; Cohen Michael S; Lonial Sagar; Khoury Hanna Jean; Fabbro Doriano; Gilliland D Gary; Bergsagel P Leif; Taunton Jack; Polakiewicz Roberto D; Chen Jing
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
Cancer cell 2007;12(3):201-14.
-
2007: Elrod Heath A; Lin Yi-Dan; Yue Ping; Wang Xuerong; Lonial Sagar; Khuri Fadlo R; Sun Shi-Yong
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.
Molecular cancer therapeutics 2007;6(7):2029-38.
-
2007: Dong Shaozhong; Kang Sumin; Gu Ting-Lei; Kardar Sean; Fu Haian; Lonial Sagar; Khoury Hanna Jean; Khuri Fadlo; Chen Jing
14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
Blood 2007;110(1):360-9.
-
2007: Richardson Paul G; Sonneveld Pieter; Schuster Michael W; Irwin David; Stadtmauer Edward A; Facon Thierry; Harousseau Jean-Luc; Ben-Yehuda Dina; Lonial Sagar; San Miguel Jesús-F; Cavenagh Jamie D; Anderson Kenneth C
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
British journal of haematology 2007;137(5):429-35.
-
2007: Mihelic R; Kaufman J L; Lonial S
Maintenance therapy in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(6):1150-7.
-
2007: Flowers Christopher R; Glover Roni; Lonial Sagar; Brawley Otis W
Racial differences in the incidence and outcomes for patients with hematological malignancies.
Current problems in cancer 2007;31(3):182-201.
-
2007: Liu Xiangguo; Yue Ping; Chen Shuzhen; Hu Liping; Lonial Sagar; Khuri Fadlo R; Sun Shi-Yong
The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Cancer research 2007;67(10):4981-8.
-
2007: Qiu Yuanzheng; Liu Xiangguo; Zou Wei; Yue Ping; Lonial Sagar; Khuri Fadlo R; Sun Shi-Yong
The farnesyltransferase inhibitor R115777 up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer cells.
Cancer research 2007;67(10):4973-80.
-
2007: Hicks Michelle L; Lonial Sagar; Langston Amelia; Flowers Christopher; Roback John D; Smith Kenneth J; Mossavi Sai Sarah; Teagarden Diane; Hamilton Ellie S; Waller Edmund K; Kaufman Jonathan
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
Transfusion 2007;47(4):629-35.
-
2007: Lonial Sagar
Designing risk-adapted therapy for multiple myeloma: the Mayo perspective.
Mayo Clinic proceedings. Mayo Clinic 2007;82(3):279-81.
-
2007: Chanan-Khan Asher A; Kaufman Jonathan L; Mehta Jayesh; Richardson Paul G; Miller Kena C; Lonial Sagar; Munshi Nikhil C; Schlossman Robert; Tariman Joseph; Singhal Seema
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study.
Blood 2007;109(6):2604-6.
-
2006: Lonial Sagar;
Management of toxicities associated with bortezomib.
Oncology (Williston Park, N.Y.) 2006;20(12):1592-3, 1597.
-
2006: Reddy G Kesava; Mughal Tariq I; Lonial Sagar
Optimizing the management of treatment-related peripheral neuropathy in patients with multiple myeloma.
Supportive cancer therapy 2006;4(1):19-22.
-
2006: Lonial Sagar; Arellano Martha; Hutcherson Donald; Langston Amelia; Flowers Christopher; Heffner L T; Winton Elliott; Jo Lechowicz Mary; Waller Edmund K
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Leukemia & lymphoma 2006;47(10):2155-62.
-
2006: Fisher Richard I; Bernstein Steven H; Kahl Brad S; Djulbegovic Benjamin; Robertson Michael J; de Vos Sven; Epner Elliot; Krishnan Amrita; Leonard John P; Lonial Sagar; Stadtmauer Edward A; O'Connor Owen A; Shi Hongliang; Boral Anthony L; Goy André
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(30):4867-74.
-
2006: Sinha Rajni; Lonial Sagar
Novel treatment approaches for patients with relapsed and refractory multiple myeloma.
Current treatment options in oncology 2006;7(3):246-57.
-
2006: Brinker Brett T; Waller Edmund K; Leong Traci; Heffner Leonard T; Redei Istvan; Langston Amelia A; Lonial Sagar
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Cancer 2006;106(10):2171-80.
-
2006: Kaufman Jonathan L; Lonial Sagar
Proteasome inhibition: novel therapy for multiple myeloma.
Onkologie 2006;29(4):162-8.
-
2006: Sinha Rajni; Kaufman Jonathan L; Lonial Sagar
Novel treatment approaches for patients with multiple myeloma.
Clinical lymphoma & myeloma 2006;6(4):281-8.
-
2006: San Miguel Jesús; Bladé Joan; Boccadoro Mario; Cavenagh Jamie; Glasmacher Axel; Jagannath Sundar; Lonial Sagar; Orlowski Robert Z; Sonneveld Pieter; Ludwig Heinz
A practical update on the use of bortezomib in the management of multiple myeloma.
The oncologist 2006;11(1):51-61.
-
2006: Zou Wei; Yue Ping; Lin Na; He Min; Zhou Zhongmei; Lonial Sagal; Khuri Fadlo R; Wang Binghe; Sun Shi-Yong
Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):273-80.
-
2005: David Ebenezer; Sun Shi-Yong; Waller Edmund K; Chen Jing; Khuri Fadlo R; Lonial Sagar
The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT.
Blood 2005;106(13):4322-9.
-
2005: Lonial Sagar; Waller Edmund K; Richardson Paul G; Jagannath Sundar; Orlowski Robert Z; Giver Cynthia R; Jaye David L; Francis Dixil; Giusti Sara; Torre Claire; Barlogie Bart; Berenson James R; Singhal Seema; Schenkein David P; Esseltine Dixie-Lee W; Anderson Jessica; Xiao Hugh; Heffner Leonard T; Anderson Kenneth C;
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma.
Blood 2005;106(12):3777-84.
-
2005: Haas Maureen; Lonial Sagar
Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.
Expert opinion on investigational drugs 2005;14(9):1161-9.
-
2005: Richardson Paul G; Sonneveld Pieter; Schuster Michael W; Irwin David; Stadtmauer Edward A; Facon Thierry; Harousseau Jean-Luc; Ben-Yehuda Dina; Lonial Sagar; Goldschmidt Hartmut; Reece Donna; San-Miguel Jesus F; Bladé Joan; Boccadoro Mario; Cavenagh Jamie; Dalton William S; Boral Anthony L; Esseltine Dixie L; Porter Jane B; Schenkein David; Anderson Kenneth C;
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.
The New England journal of medicine 2005;352(24):2487-98.
-
2005: Everly Jason J; Lonial Sagar
Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity.
Expert opinion on biological therapy 2005;5(3):293-311.
-
2004: Lonial Sagar; Hicks Michelle; Rosenthal Hilary; Langston Amelia; Redei Istvan; Torre Claire; Duenzl Mary; Feinstein Bonita; Cherry Judith; Waller Edmund K
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):848-57.
-
2004: Waller Edmund K; Giver Cynthia R; Rosenthal Hilary; Somani Jyoti; Langston Amelia A; Lonial Sagar; Roback John D; Li Jian-Ming; Hossain Mohammad S; Redei Istvan
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Blood cells, molecules & diseases 2004;33(3):233-7.
-
2004: Kaufman Jonathan; Lonial Sagar
Multiple myeloma: the role of transplant and novel treatment strategies.
Seminars in oncology 2004;31(2 Suppl 4):99-105.
-
2004: Lonial Sagar
Immunomodulation: the role of hematopoietic cytokines.
Supportive cancer therapy 2004;1(2):80-8.
-
2004: Giver Cynthia R; Li Jian-Ming; Hossain Mohammad S; Lonial Sagar; Waller Edmund K
Reconstructing immunity after allogeneic transplantation.
Immunologic research 2004;29(1-3):269-82.
-
2003: Lonial Sagar
Hematopoietic cytokines: when treating the symptoms does not treat the disease.
Supportive cancer therapy 2003;1(1):36-7.
-
2003: Giver Cynthia R; Montes Richard O; Mittelstaedt Stephen; Li Jian-Ming; Jaye David L; Lonial Sagar; Boyer Michael W; Waller Edmund K
Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(10):616-32.
-
2003: Lonial Sagar; Waller Edmund K; Simons Jonathan W; Heffner L T
Signal transduction and myeloma: new targets, new hope.
Cancer biology & therapy 2003;2(4):310-9.
-
2003: Waller Edmund K; Langston Amelia A; Lonial Sagar; Cherry Judy; Somani Jyoti; Allen Andrew J; Rosenthal Hilary; Redei Istvan
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):460-71.
-
2003: Heffner Leonard T; Lonial Sagar
Breakthroughs in the management of multiple myeloma.
Drugs 2003;63(16):1621-36.
-
2002: Somani Jyoti; Lonial Sagar; Rosenthal Hilary; Resnick Suzanne; Kakhniashvili Irina; Waller Edmund K
A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses.
Vaccine 2002;21(3-4):221-30.
-
2002: Redei I; Langston A A; Lonial S; Cherry J K; Allen A J; Hamilton E; Jones M; Bartlett V M; Waller E K
Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
Bone marrow transplantation 2002;30(6):335-40.
-
2002: Langston Amelia A; Redei Istvan; Caliendo Angela M; Somani Jyoti; Hutcherson Don; Lonial Sagar; Bucur Silvana; Cherry Judy; Allen Andrew; Waller Edmund K
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
Blood 2002;99(3):1085-8.
-
2001: Waller E K; Rosenthal H; Jones T W; Peel J; Lonial S; Langston A; Redei I; Jurickova I; Boyer M W
Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.
Blood 2001;97(10):2948-56.
-
2001: Lonial S; Bomberger C; Waller E K
Changes in the pattern of TCR V beta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans.
British journal of haematology 2001;113(1):224-30.
-
2000: Lonial S; Jones T W; Devine S; Winton E F; Heffner L T; Smith K J; Yeager A M; Waller E K
High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma.
Leukemia & lymphoma 2000;36(5-6):497-502.
-
1999: Lonial S; Bilodeau P A; Langston A A; Lewis C; Mossavi-Sai S; Holden J T; Waller E K
Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature.
Bone marrow transplantation 1999;24(12):1337-41.
-
1999: Waller E K; Ship A M; Mittelstaedt S; Murray T W; Carter R; Kakhniashvili I; Lonial S; Holden J T; Boyer M W
Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
Blood 1999;94(9):3222-33.
Sign-in to see more
